Pines Shai Insider Trades

Insider Trading History

Track insider trading activity for Pines Shai. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Pluristem Therapeutics
Pluristem Therapeutics PSTI
Director
Holding Value $210k 209,708 shares
Last Trade
Dec 21, 2011 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.29M 50,000 shares
$25.80
$1.00
Pluri
Pluri PLUR
Director
Holding Value $499k 209,708 shares
Last Trade
Dec 21, 2011 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$128k 50,000 shares
$2.55
$2.38
Pluri
Pluri PLUR
Director
Holding Value $380k 159,708 shares
Last Trade
May 18, 2011 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$128k 42,860 shares
$2.99
$2.38
Pluristem Therapeutics
Pluristem Therapeutics PSTI
Director
Holding Value $160k 159,708 shares
Last Trade
May 18, 2011 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.28M 42,860 shares
$29.90
$1.00
Pluristem Therapeutics
Pluristem Therapeutics PSTI
Director
Holding Value $117k 116,848 shares
Last Trade
Oct 28, 2010 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$624k 40,000 shares
$15.60
$1.00
Pluri
Pluri PLUR
Director
Holding Value $278k 116,848 shares
Last Trade
Oct 28, 2010 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$63.2k 40,000 shares
$1.58
$2.38
Pluri
Pluri PLUR
Director
Holding Value $183k 76,848 shares
Last Trade
May 10, 2010 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.34k 3,648 shares
$1.19
$2.38
Pluri
Pluri PLUR
Director
Holding Value $183k 76,848 shares
Last Trade
May 10, 2010 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.34k 3,648 shares
$1.19
$2.38
Pluristem Therapeutics
Pluristem Therapeutics PSTI
Director
Holding Value $76.8k 76,848 shares
Last Trade
May 10, 2010 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$43.4k 3,648 shares
$11.90
$1.00
Pluri
Pluri PLUR
Director
Holding Value $174k 73,200 shares
Last Trade
Dec 22, 2009 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$42.4k 35,000 shares
$1.21
$2.38
Pluristem Therapeutics
Pluristem Therapeutics PSTI
Director
Holding Value $73.2k 73,200 shares
Last Trade
Dec 22, 2009 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$427k 35,000 shares
$12.20
$1.00
Pluristem Therapeutics
Pluristem Therapeutics PSTI
Director
Holding Value $38.2k 38,200 shares
Last Trade
May 11, 2009 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$47.2k 3,200 shares
$14.74
$1.00
Pluri
Pluri PLUR
Director
Holding Value $90.9k 38,200 shares
Last Trade
May 11, 2009 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.74k 3,200 shares
$1.48
$2.38
Pluri
Pluri PLUR
Director
Holding Value $83.3k 35,000 shares
Last Trade
Feb 12, 2009 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$41.7k 35,000 shares
$1.19
$2.38
Pluristem Therapeutics
Pluristem Therapeutics PSTI
Director
Holding Value $35k 35,000 shares
Last Trade
Feb 12, 2009 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$441k 35,000 shares
$12.60
$1.00

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up